SMS Pharmaceuticals Limited
NSE: SMSPHARMAINE812G01025·Healthcare·www.smspharma.com ↗·Mcap ₹4,522 Cr·Listed 2007
₹475.00▲ ₹0.95  (0.20%)
52W: ₹242 – ₹494 · Vol: 3.6L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY17
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY17
Revenue from operations20723821024219624817319716424616116713514914915964.460.912117516317114913011396.580.41181170
Other income1.72.63.81.40.61.42.11.31.41.61.50.80.51.32.20.60.80.42.11.41.31.30.90.90.83.10.80.60.70
Total expenses1822131832101722211531791442261461521231401441597877.710714113213812311599.990.968.71041020
EBITDA4139.943.648.439.440.833.231.533.533.62927.826.223.218.513.6−0.8−4.42746.844.441.134.523.721.414.42022.223.40
EBITDA margin19.8%16.8%20.7%20.0%20.1%16.4%19.2%16.0%20.4%13.7%18.0%16.7%19.3%15.6%12.4%8.5%-1.3%-7.3%22.3%26.8%27.3%24.0%23.2%18.2%19.0%14.9%24.9%18.8%20.0%–
Finance costs5.55.36.25.75.85.14.24.64.75.665.66.35.95.95.24.94.34.84.852.52.92.72.92.92.933.40
Depreciation1010.110109.88.68.78.68.47.987.97.788.18.17.988.18.185.55.65.65.565.45.45.30
Profit before tax27.227.131.23424.428.522.419.521.821.716.515.212.710.66.70.8−12.8−16.316.335.232.834.326.716.313.88.612.514.415.30
Tax76.188.95.78.45.45.75.55.74.23.13.92.61.40.1−2.6−25.26.110.29.612.18.454.62.454.95.90
Net profit20.932.723.525.320.520.318.214.116.517.311.511.79.36.23.8−2−12.86.210.32323.223.121.411.276.27.59.59.50
Net margin10.1%13.7%11.2%10.4%10.5%8.2%10.5%7.2%10.0%7.0%7.1%7.0%6.9%4.2%2.5%-1.3%-19.8%10.1%8.5%13.2%14.2%13.5%14.4%8.6%6.2%6.5%9.3%8.1%8.1%–
EPS (₹)2.233.582.592.842.312.402.151.691.952.041.361.391.100.730.44-0.24-1.510.731.072.722.742.732.531.330.830.760.901.170.920.00
Net profit YoY+2.0%+61.0%+28.7%+79.5%+24.3%+17.6%+58.9%+20.2%+76.4%+177.9%+205.0%+683.8%+173.2%+0.7%−63.3%−108.7%−155.0%−73.3%−52.0%+105.1%+230.1%+270.3%+185.2%+17.6%−25.9%–––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY17
Revenue from operations8877837095225205634120
Other income8.46.24.54.95.23.55.10
Total expenses7796976485224574763660
EBITDA17113911754.511412179.90
EBITDA margin19.3%17.8%16.4%10.4%22.0%21.5%19.4%–
Finance costs23.118.523.521.918.911.212.20
Depreciation39.934.331.532.132.222.322.10
Profit before tax11792.366.15.368.591.150.80
Tax28.624.916.91.50.630.218.10
Net profit10269.149.8−7.162.262.532.70
Net margin11.5%8.8%7.0%-1.4%12.0%11.1%7.9%–
EPS (₹)11.158.165.89-0.837.357.393.730.00
Net profit YoY+47.5%+38.8%+805.8%−111.3%−0.5%+91.3%––
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow59.281.750.122.540.2
Investing cash flow−131−123−52.1−29.7−27.2
Financing cash flow7647.130.7−32−6.9
Capital expenditure13112352.229.927.2
Free cash flow (CFO − capex)−71.3−41.7−2−7.513

Net profit trend

annual, ₹ crore
FY21
₹62.5
FY22
₹62.2−0%
FY23
₹−7.1−111%
FY24
₹49.8+806%
FY25
₹69.1+39%
FY26
₹102+48%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated31 Jul 2026PDF on NSE XBRL
Q1 FY27Standalone31 Jul 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited22 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited22 May 2026PDF on NSE XBRL
Q3 FY26Consolidated7 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone7 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated8 Nov 2025PDF on NSE XBRL
Q2 FY26Standalone8 Nov 2025PDF on NSE XBRL
Q1 FY26Consolidated9 Aug 2025PDF on NSE XBRL
Q1 FY26Standalone9 Aug 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 32.2×43.4×
P/B5Y avg 3.14×5.66×
ROEFY26, on average equity14.3%
Net margin11.5%
Debt / equity0.46×
Revenue CAGR (3Y)19.3%
Profit CAGR (3Y)–
EPS (TTM)₹10.93
Market cap₹4,448 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
5.66×
vs 8-point avg 3.14× (+80%)
1.18× low3.14× avg5.83× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹1,362 Cr+18%
Net worth₹786 Cr+23%
Total borrowings₹365 Cr+17%
Cash & bank balances₹46 Cr+11%
Investments₹26 Cr+125%
Inventories₹351 Cr+23%
Trade receivables₹216 Cr+6%
Trade payables₹120 Cr+6%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Sept 25Jun 25Mar 25Mar 25Dec 24Sept 24Jun 24Mar 24
Promoter68.0768.0768.0768.0768.0766.2666.2666.2664.6764.6764.6764.67
FII0.650.310.040.280.170.030.080.080.310.520.170.17
DII2.833.023.212.882.883.032.432.432.552.552.131.98
of which MF2.812.963.212.882.883.03––––––
Retail24.0423.1724.0824.0224.3625.8926.3526.3527.3827.0427.8127.93
Other public4.415.434.604.754.524.794.884.885.095.225.225.25
31,489 shareholders · NSE shareholding pattern filings.